Clinical Trial

A Study of Olanzapine in Participants With Bipolar Disorder.

Name: A Study of Olanzapine in Participants With Bipolar Disorder. — clinical trial record (NCT07263191)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.

Trial Details

NCT Number	NCT07263191
Lead Sponsor	Boryung Pharmaceutical Co., Ltd
Conditions	Bipolar Disorder
Enrollment	3,000 participants
Start Date	2025-10-30
Primary Completion	2027-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2025-12-04